BFR Risk
Pre-treatment risk screening for blood flow restriction. Built on the APTA VTE CPG (2022), Padua, Caprini, and Wells instruments. Every recommendation shows its work. Intended for use by licensed clinicians within their scope of practice.
Zero data leaves this page. Nothing is stored or transmitted. No patient identifiers are collected — add identifiers in your own EMR.
Disclaimer · read before use
This tool is a preliminary decision-support aid. It synthesizes published instruments — the APTA Venous Thromboembolism Clinical Practice Guideline (2022), the Padua Prediction Score, the Caprini Risk Assessment Model, the Wells DVT criteria, and published BFR contraindication frameworks (Kacin 2015; AIS 2021). It is NOT a validated BFR-specific instrument, it does not diagnose or rule out DVT, and it does not replace clinical judgment or physician clearance. Blood flow restriction carries risks that are incompletely characterized in medically complex and post-surgical patients. Intended for use by licensed clinicians within their scope of practice.
Citations
APTA VTE CPG 2022: Hillegass E, Lukaszewicz K, Puthoff M. Phys Ther. 2022;102(8):pzac057. PMID 35567347.
Download this tool for offline use
Changelog
Evidence reviewed 2026-08-17. Get notified when the evidence version updates
SIDELINE · THE METHOD ·